In vitro naive CD4+ T cells differentiation upon treatment with miR-29b-loaded exosomes from Mesenchymal Stem Cells

doi:10.21203/rs.3.rs-2982283/v1

Download PDF

Research Article

In vitro naive CD4⁺ T cells differentiation upon treatment with miR-29b-loaded exosomes from Mesenchymal Stem Cells

https://doi.org/10.21203/rs.3.rs-2982283/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 19 Sep, 2023

Read the published version in Molecular Biology Reports →

You are reading this latest preprint version

Background: Gene regulation by microRNA is central in T cell differentiation processes. Here, we investigate miR-29b roles in the reprogramming of T cell differentiation, which can be a promising therapeutic avenue for various types of inflammatory disorders such as rheumatoid arthritis and multiple sclerosis.

Methods and Results: Adipose Mesenchymal Stem Cell derived exosomes (AMSC-Exo) enriched with miR-29b were delivered into naive CD4⁺ T cells (nCD4⁺) cells. The expression level of some important transcription factors including RORγt, GATA3, T-bet, and Foxp3 was determined by quantitative Real-Time PCR (qPCR). Moreover, flow cytometry and Enzyme-linked Immunosorbent Assay (ELISA) was respectively used to measure the frequency of T regulatory cells and the levels of cytokines production (IL-17, IL-4, IFN-γ, and TGF-β). This study indicates that the transfection of miR-29b mimics into T lymphocytes through AMSC-Exo can alter the CD4⁺ T cells differentiation into other types of T cells.

Conclusions: In conclusion, AMSC-Exo-based delivery of miR-29b can be considered as a new fascinating avenue for T cell differentiation inhibition and the future treatment of several inflammatory disorders.

Mesenchymal Stem Cells

Exosomes

miR-29b

T cells differentiation

naive CD4+ T cells.

CD4⁺ lymphocytes are key players in the adaptive immunity [1]. Based on cytokines and cellular environment, the naive CD4⁺ T cells (nCD4⁺) activation leads to differentiation into effector and regulatory subsets of T helper (Th) cells, which play central roles in fighting against tumor cells and infectious diseases [2]. Therefore, the appropriate regulation of Th cell differentiation and programming is an integral part of the immune system response against pathogens. Disruption of the regulation of Th cell differentiation can cause numerous autoimmune diseases [3, 4].

It has been demonstrated that cytokines, costimulatory molecules, and antigens are important contributors in determining the differentiation fate of nCD4⁺ cells [5]. Although using cytokines is a common strategy for in vitro differentiation of nCD4⁺ cells as they regulate the expression of transcription factors, several recent studies elucidated that microRNA-based systems can be efficiently used as a robust strategy to control CD4⁺ T cells differentiation because they control the expression of not only lineage-specific transcription factors but also cytokines [6–8].

miR29b is a vital contributor in nCD4⁺ cell fate decision. It has been shown that miR-29 family can inhibit nCD4⁺ cells differentiation into Th1 cells by suppressing of IFNγ, T-bet, and Eomesodermin expression [9]. Further studies suggest that the suppression of miR-29a/b expression upon intracellular bacterial infections increases the production of IFNγ by initiating a positive feedback loop, which increases cell resistance to infections [10].

Several delivery approaches have been developed for safe and efficient delivery of miRNAs [11–13]. Recently, using exosomes, spherical extracellular vesicles (between 40–150 nm diameter), as a miRNA delivery system has attracted much attention; because of poor immunogenicity, low toxicity, and high packaging capacity [14–16]. Electroporation is a gold standard technique for miRNAs loading into exosomes [17].

Here, we have investigated the roles of miR-29b-enriched Adipose Mesenchymal Stem Cell derived exosomes (AMSC-Exo) in nCD4⁺ cell fate decision. Hence, the miR-29b-enriched exosomes were delivered into nCD4⁺ cells, and then their differentiation was studied by measuring the profile of gene expression, cytokine production, and regulatory T cells frequency.

Mice

Female mice (6–8 weeks) of the C57BL/6 strain were purchased from the Royan Institute (Tehran, Iran) and were housed and manipulated in accordance with the ethical committee’s guidelines of Shahid Beheshti University of Medical Sciences (66001030). Three to 5 mice were used in each experimental group.

AMSCs isolation and culture from adipose tissue

Liposuction aspirates were obtained from abdomen of five different donors (healthy adult aged 25–40 years) with written informed consent. All procedures were performed in accordance with the ethical committee guidelines of Shahid Beheshti University of Medical Sciences (66001030). A previously described collagenase digestion method was used to AMSCs isolation [18]. In brief, 0.075% type I collagenase (Gibco, Grand Island, NY) was used for adipose tissue dissociation at 37°C for 20 min. After collagenase neutralization by FBS, the samples were centrifuged and the pellet was cultured at 37°C in DMEM/F12 (Dulbecco modified Eagle medium) plus 10% Fetal Bovine Serum (FBS) (Gibco, Rockville, MD) and 100 U/ml streptomycin/penicillin in a 5% CO2 humidified incubator. Next day nonadherent cells were removed and medium was changed. The half of media was changed every 3 days and adherent cells were grown to 80% confluency. The cells were used at passage 3 for the following experiments.

AMSCs characterization

The AMSCs at passage 3 were characterized by phenotyping of surface markers using FACSCalibur analyzer (Becton Dickinson, San Jose, CA, USA). In short, cells were detached and washed with Phosphate-Buffered Saline (PBS). Then Phycoerythrin (PE)-labeled antibodies against CD90, CD34, CD105, CD14, CD73, and CD45 (all from eBioscience, San Diego, CA) were used for surface antigens labeling. Flowjo (Tree Star, Inc., Ashland, OR) was used for data analysis.

Besides, the AMSCs were also identified by the induction of mesenchymal lineages differentiation via osteogenic and adipogenic differentiation media as described previously [18].

Exosomes purification from AMSCs conditioned media

To exosomes isolation, first, AMSCs were adapted to serum-free medium [19]. AMSCs were cultured in descending concentration of FBS in presences of 1% insulin/transferrin/selenium (Invitrogen, Carlsbad, CA, USA). After reaching 0% FBS, conditioned media was collected every 3 days, and exosomes were isolated using an isolation kit from Cibbiotech (Tehran, Iran) according to the instructions provided with the kit. In short, supernatants were filtered by a 0.22 µm filter and centrifuged for 20 min at 3000g to remove cell debris. Supernatants were then incubated with exosome precipitation buffer (5:1 ratio) overnight at 4°C to precipitate exosomes. The samples were centrifuged at 4°C for 40 min at 3000g and pellets were resuspended in 200µL PBS and stored at -70°C. The protein content of isolated exosomes was calculated using a bicinchoninic acid protein assay kit (Parstous, Mashad, Iran).

Scanning electron microscopy examination

The shape and size of the purified exosomes were examined with Scanning Electron Microscopy (SEM). To do this, Specimens were prepared by fixing 10µL exosomes with 2.5% glutaraldehyde (Sigma–Aldrich, St. Louis, MO). After dehydration in increasing concentrations of ethanol, they were left to dry at room temperature. Finally, the samples were evaluated under SEM (MIRA3 TESCAN, Brno, Czech Republic) at 30 kV following gold-palladium sputtering.

Transmission electron microscopy examination

For morphology analysis of purified exosomes from AMSCs, after fixing with 2.5% glutaraldehyde and dehydration in ascending sequence of ethanol, the samples were further proceed for epoxy resin (PolySciences, Warrington, PA, USA) embedding in accordance with the manufacturer's instruction. Ultrathin sections (a thickness of maximum 70 nm) were loaded onto formvar coated copper grids, contrasted with uranyl acetate, and visualized by Zeiss-EM10C (Germany) transmission electron microscope (TEM).

Exosomes size distribution analysis

Dynamic light scattering (DLS) measured the size distribution and average size of small particles. Exosomes obtained from the supernatants of AMSCs were diluted 1:10 in PBS and examined by Malvern Zetasizer (Worcestershire, UK).

Exosomes Immunophenotyping

To further characterization, exosomes immunophenotyping was performed using antibodies against CD63 and CD81 (important markers of exosomes). The data were collected via flow cytometry. The relative fluorescence was calculated by Flowjo (Tree Star, Inc., Ashland, OR).

miR-29b1-3p mimic loading into exosomes

In order to loading of exosomes with miR-29b1-3p mimic, 100 µg of purified exosomes were gently diluted with EDTA (1 mM) containing electroporation buffer (1:1 v/v). 100 pm of miR-29b1-3p mimic (Exiqon, Vedbaek, Denmark) was added to the electroporation sample, mixed thoroughly, and transferred into 4 mm cuvettes (All procedures were performed on ice) and electroporated by Eppendorf Multiporator (Eppendorf AG, Hamburg, Germany). The electric conditions were double pulses of 400 V and 100 µs. The unincorporated free miR-29b was removed by 5 µg/ml RNase A (Sigma-Aldrich, St. Louis, MO) and exosomes re-isolation by isolation kit (Cibbiotech, Tehran, Iran).

Splenocytes isolation and nCD4 cell purification

Spleens were removed from mice and subjected to mechanically disruption and homogenization. The homogenates were centrifuged for 5 min in 400g at 4°C. Then, erythrocytes were lysed at room temperature in ACK lysis buffer for 4 min, followed by additional centrifugation. The cell pellets were resuspended in RPMI-1640 medium (Life Technologies, Carlsbad, CA) plus 5% FBS and the count of splenocytes was measured by a Neubauer counting chamber. Splenocytes were subjected to magnetic-activated cell sorting for nCD4⁺ cells isolation. nCD4⁺ cells were purified from splenocytes by Miltenyi Biotech naive CD4⁺ T cell isolation kit II (Bergisch Gladbach, Germany) according to the instructions provided with the kit. First, non-CD4⁺ T cells were depleted from splenocytes via a cocktail of biotin-conjugated antibodies. Then, positive selection was used to isolate CD62L⁺ cells. The CD4⁺CD62L⁺ T cells was analyzed by flow cytometry and the purity was 86% (Fig. 3a).

Exosomes treatment

Isolated nCD4⁺ cells were seeded in RPMI-1640 plus 5% FBS, at the cell concentration of 1×10⁶ per well in 24-well culture plates, and activated by anti-CD28 (10 µg/ml) and anti-CD3 (2 µg/ml) Abs (Invitrogen, Carlsbad, CA) for 4 hours. Then, the cells were co-incubated for 5 days with 200 µg/ml exosomes or miR-29b-3p loaded exosomes. RPMI-1640 with 5% FBS with or without 5 ng/ml TGF-β1 (eBioscience, San Diego, CA, USA) was used as a negative or positive control, respectively.

PKH67 labeling of exosomes

For exosome uptake examination, purified exosomes (200 µg protein) were fluorescently labeled by PKH67 (Sigma-Aldrich, St. Louis, MO). Exosomes were resuspended in 250 µL Diluent C and 2 µL of PKH67 dye was also diluted in the same amount of Diluent C and then they were mixed gently. After 5 min incubation at room temperature, the staining reaction was stopped by 250 µL of FBS and exosomes re-isolated via isolation kit to get rid of the excess dyes. Labeled exosomes were co-incubated with nCD4⁺ cells for 24 hours, and then the cells were washed with PBS, fixed with 2.5% glutaraldehyde, and observed using a Leica TCS SPE (Leica, Mannheim, Germany) confocal microscope. For the negative control, above labeling procedure was performed on a mixture without exosomes.

ELISA of cytokines

The ELISA assay was used to determine IL-17, IL-4, IFN-γ, and TGF-β concentrations. After 5 days of cell culture, cell-free supernatants were collected and the cytokine were quantified via R&D Systems ELISA kit (Minneapolis, MN, USA) following the manufacturer’s protocol. Cells were harvested, washed, and used for qPCR and flow cytometry analysis (see below).

Real-time PCR assay

To miR-29b and transcription factors expression analysis 5 days following nCD4⁺ cells co-culturing with exosomes, TRIzol Reagent (Life Technologies, Grand Island, NY) was used for total RNA isolation. The RNA concentration was determined via a NanoDrop spectrophotometer and then reverse transcribed to cDNA. RNA quantification was performed using a standard SYBR Green I reaction mix (Ampliqon, Odense, Denmark) on an ABI StepOne™ (Applied Biosciences, Foster City, CA). U47 and β-2M were used as background control [13].

Analysis of regulatory T cells frequency

The frequency of regulatory T cells was determined by staining with Miltenyi Biotech CD4/CD25/Foxp3 Treg detection kit (Germany) in accordance with the manufacturer’s instructions. Single-cell suspensions were incubated first with FITC-conjugated-CD4 Abs and APC-conjugated-CD25 Abs at 4°C in dark for 10 min. These cells were subsequently fixed and permeabilized to intracellular transcription factor staining by PE-conjugated-Foxp3 Abs. Data was acquired using FACSCalibur and analysis was performed by Flowjo.

Statistical data analysis

All data are the mean of 3 independent experiments with standard deviation (SD) in triplicate. One-way analysis of variance in GraphPad Prism 7.0 (GraphPad, San Diego, CA) was used to measure p-values and a p-value less than 0.05 was considered statistically significant.

AMSCs characterization

Fibroblast-like stem cells were obtained from adipose tissue of healthy individuals and light microscopy analysis (Fig. 1a) showed plastic adherence cells with spindle-shaped morphology. The differentiation potential of these cells was evaluated by culturing in the appropriate induction media. Three weeks following culture in adipogenic or osteogenic differentiation medium, accumulated triacylglycerol was identified by Oil red O staining (Fig. 1b) and calcium depositions were assessed using Alizarin red S (Fig. 1c). Finally, immunophenotyping of isolated cells was displayed as histograms in Figs. 1d and showed that 73.5%, 93.3%, and 76.4% of the cells were respectively expressed CD105, CD90, and CD73, but they had a little expression of CD45, CD34, and CD14. These data confirmed the purity and identity of AMSCs.

Identification of exosomes

The particles secreted from AMSCs were characterized by DLS, TEM, and SEM. The morphology examination by SEM showed nano-sized cup-shaped vesicles (Fig. 2a). Furthermore, the assessment of purified particles with TEM showed typical vesicular structures (Fig. 2b). As shown in Fig. 2c, DLS analysis also revealed that these particles ranged almost from 30 to 90 nm in diameters (average size 48 nm). Finally, immunophenotyping showed isolated vesicles were positive for CD63 and CD81 exosome markers (Fig. 2d). All these data indicated that the vesicles obtained from the conditional media have the characteristics of exosomes.

Exosomes were internalized by nCD4 cells and miRNA-29b were delivered into the cells

To evaluate the internalization capacity of exosomes by nCD4⁺ cells, exosomes were stained by PKH67 dye and then co-cultured with nCD4⁺ cells. 24 hours later, the uptake of the fluorescent exosomes by nCD4⁺ cells was visualized under fluorescence and also confocal microscopy. As shown in Fig. 3c, fluorescence microscopy images indicated that almost all nCD4⁺ cells revealed a green signal, suggesting exosomes have been efficiently taken up by nCD4⁺ cells. These findings were validated by data from confocal microscopy that showed exosomes internalization and accumulation in the cytoplasm, especially in the perinuclear region (Fig. 3d). PKH26 micelles were not detected in control negative group, which showed they could not develop artefacts.

In addition, following the exosomes uptake, miR-29b levels increased in nCD4⁺ cells and confirmed miR-29b delivery to nCD4⁺ cells. qPCR analysis showed that 24 hours and 5 days upon co-culturing a significant increase (p ≤ 0.0001) in the expression level of miR-29b was observed The cytokine production change upon miR-29b loaded exosomes treatment

Next, we investigate the underlying mechanism of nCD4⁺ cells differentiation. After five days of treatment with miR-29b-enriched exosomes, the secretion of IL-17, IL-4, IFN-γ, and TGF-β from T cells during activation and differentiation was assessed. miR-29b-enriched exosomes can significantly suppress the production of IL-17 and IL-4 in comparison with other groups (p ≤ 0.05). In addition, no change was seen in the IFN-γ expression in miR-29b-enriched exosomes compared to TGF-β treated and control cells. Moreover, no induction was detected in the expression of TGF-β in miR-29b-enriched exosomes groups (Fig. 4).

Tbx21 and RORγt expression inhibition in nCD4 cells following miR-29b enriched exosomes treatment

Next, we explored the regulatory mechanism of miR-29b-enriched exosomes on nCD4⁺ cells differentiation. nCD4⁺ cells were treated with miR-29b-enriched exosomes. After 5 days of incubation, total RNA was prepared and the expression of some important transcription factors in the differentiation of T cells such as Foxp3 (Treg), Tbx21 (Th1), GATA3 (Th2), and RORγt (Th17) was assessed by qPCR assay. Figure 5 shows the expression of Tbx21 was considerably decreased in exosomes and miR-29b-enriched exosomes compared to the control group (p ≤ 0.05 and p ≤ 0.001, respectively). Similarly, the Tbx21 expression level was also reduced in TGF-β1 treated cells (p ≤ 0.001). Both miR-29b and TGF-β1 inhibit the differentiation of nCD4⁺ cells to Th1 cells. Our results also showed a decrease in the expression of GATA3 in miR-29b-loaded exosomes compared to that of exosomes treated cells (p ≤ 0.01). Interestingly, the RORγt expression, a critical transcription factor in Th17 cell differentiation, was significantly decreased in miR-29-enriched exosomes (p ≤ 0.01). Furthermore, an increase in the Treg transcription factor, Foxp3, expression was detected in the exosomes group (p ≤ 0.05) in comparison with the control group. TGF-β1 increased both RORγt and Foxp3 expression compared to other groups (p ≤ 0.0001).

Increased CD4CD25Foxp3 Cells frequency upon miR-29b loaded exosomes treatment

Flow cytometry was used to delineate the role of miR-29b on the frequency of CD4⁺CD25⁺Foxp3⁺ T Cells. Figure 6 shows that when cells were treated with miR-29b-enriched exosomes, the CD4⁺CD25⁺Foxp3⁺ Treg cells frequency was enhanced significantly (p ≤ 0.001).

According to the previous studies, miR-29b has a significant role in CD4⁺ T cell fate regulation and it has immunomodulatory effects [9, 10, 20–22]. Due to poor immunogenicity, low toxicity, and high packaging capacity, herein we used AMSC-Exo as promising delivery systems for miRNAs. This study revealed the ability of AMSC-Exo loaded with miR-29b to regulate the T cells differentiation to different type of helper T cells, via not only suppression of IL-4 and IL-17 but also inhibition of several transcription factors including Tbx21 and RORγt.

Previous studies demonstrated that the regulation of the IFN-γ production has a key role in proper immune responses and has been regarded as a central contributor in setting the balance between regulatory and helper T cells during inflammatory immune responses and cancer development [23]. In addition, Steiner and his co-workers established that miR-29a and miR-29b could be vital inhibitors of the Th1 cell fate by using DGCR8-/- miR-deficient CD4⁺ T cells [9]. In agreement with these observations, we confirmed that miR-29b-loaded AMSCs exosomes could decrease the expression of the Tbx21, a transcription factor that plays significant role in the process of Th1 cell differentiation, in nCD4⁺ cells.

Some reports revealed that MSCs-derived exosomes are the main contributors in the conversion of Th1 into Th2 cells by changing the expression of several cytokines [24, 25]. Furthermore, our results concur well with the fact that Tbx21 could suppress T cells differentiation to Th2 [26]. As a result, we believe that the suppression of Th1 differentiation is highly related to miR-29b because the expression of GATA3 was suppressed in the presence of the exosomes enriched with miR-29b compared to the exosomes group. We also observed Tbx21 downregulation following the TGF-β addition, which is in complete agreement with a study by Gorelik and et. al., where they demonstrated the inhibitory role of TGF-β on Tbx21 expression [27].

We also detected an increase in the population of CD4⁺CD25⁺Foxp3⁺ Treg cells while the expression of Foxp3 was increased in the presence of miR-29b-enriched AMSCs derived exosomes and TGF-β. This lends support to studies showed that Foxp3 induction is essential for efficient Treg differentiation of nCD4⁺ cells [28].

Simultaneously, we revealed a decrease in the expression of the RORγt following the treatment of nCD4⁺ cells with miR-29b-enriched AMSCs derived exosomes, which leads to a high miR-29b-mediated Th17 differentiation inhibition. In addition, the production of IL-17, which is one of the most important cytokines in Th17 cells, was reduced, confirming inhibition of nCD4⁺ cells differentiation into the Th17 cells. Our experiments are in line with previous results by Xuan who showed downregulation of IL-17 and decreased quantity in Th17 cells upon miR-29 mimic delivery into CD4⁺ cells [29]. One mechanism for RORγt inhibition by miR-29 could be the inhibitory effect of miR-29 on L-12p40 and IL-23p19, which leads to decreased expression of IL-23 [30].

Our research showed the impacts of miR-29b carried by AMSC-Exo on CD4⁺ T cell subsets differentiation. These findings suggest that miR-29b is a key player in both inhibition of Th1 and Th17 differentiation and induction of Treg differentiation from nCD4⁺ cells. However, further studies seem to be essential to reveal the molecular pathway for DIFFERENTIATION regulation BY miR-29b. Moreover, clinical studies should be also addressed in future researches.

In this study, we established that miR-29b-enriched AMSCs derived exosomes are important contributors in the inhibition of nCD4⁺ cells differentiation to Th1, and Th17. These findings will greatly lead us to develop novel strategies for the treatment of various inflammatory diseases like autoimmune diseases.

AMSC-Exo - Adipose Mesenchymal Stem Cell derived exosomes

DLS - Dynamic light scattering

ELISA - Enzyme-linked Immunosorbent Assay

FBS - Fetal Bovine Serum

nCD4⁺ - naive CD4⁺ T cells

Th - T helper

qCR - quantitative Real-Time PCR

PBS - Phosphate-Buffered Saline

PE - Phycoerythrin

SEM - Scanning Electron Microscopy

SD - Standard deviation

Acknowledgements

The authors would like to thank the Iranian Stem Cell Council and Shahid Beheshti University of Medical Sciences for their kindly cooperation.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author, upon reasonable request.

Funding

This work was supported by the Iranian Stem Cell Council (Grant No: 6604) and Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Competing Interests

The authors have no financial interests.

Authors Contributions

Zohreh Bolandi: Investigation, Formal analysis, Methodology, Data curation, Writing-original draft, Writing-review & editing. Seyed Mahmoud Hashemi: Supervision, Project administration, Conceptualization, Writing - review & editing. Mozhgan Abasi: Investigation, Writing-original draft. Shahin Aghamiri: Investigation, Writing-original draft, Hossein Ghanbarian: Conceptualization, Fuding acquisition, Visualization, Project administration, Supervision, Writing-review & editing.

Ethics Approval and Consent to Participate

Informed consent was obtained from all individual participants included in the study.

Consent for Publication

The authors affirm that human research participants provided informed consent for publication.

Hepworth, M. R., Monticelli, L. A., Fung, T. C., Ziegler, C. G. K., Grunberg, S., Sinha, R., … Sonnenberg, G. F. (2013). Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature, 498(7452), 113–117. https://doi.org/10.1038/nature12240
Zhou, L., Chong, M. M. W., & Littman, D. R. (2009). Plasticity of CD4⁺ T Cell Lineage Differentiation. Immunity, 30(5), 646–655. https://doi.org/10.1016/j.immuni.2009.05.001
Rudd, B. D. (2020). Neonatal T Cells: A Reinterpretation. Annual review of immunology, 38, 229–247. https://doi.org/10.1146/annurev-immunol-091319-083608
O’Shea, J. J., & Paul, W. E. (2010). Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science (New York, N.Y.), 327(5969), 1098–1102. https://doi.org/10.1126/science.1178334
Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G., & Glimcher, L. H. (2000). A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment. Cell, 100(6), 655–669. https://doi.org/10.1016/S0092-8674(00)80702-3
Groom, J. R. (2019). Regulators of T-cell fate: Integration of cell migration, differentiation and function. Immunological Reviews, 289(1), 101–114. https://doi.org/https://doi.org/10.1111/imr.12742
Coomes, S. M., Pelly, V. S., & Wilson, M. S. (2013). Plasticity within the alphabeta(+)CD4(+) T-cell lineage: when, how and what for? Open biology, 3(1), 120157. https://doi.org/10.1098/rsob.120157
Mehta, A., & Baltimore, D. (2016). MicroRNAs as regulatory elements in immune system logic. Nature Reviews Immunology, 16(5), 279–294. https://doi.org/10.1038/nri.2016.40
Steiner, D. F., Thomas, M. F., Hu, J. K., Yang, Z., Babiarz, J. E., Allen, C. D. C., … Ansel, K. M. (2011). MicroRNA-29 Regulates T-Box Transcription Factors and Interferon-g; Production in Helper T Cells. Immunity, 35(2), 169–181. https://doi.org/10.1016/j.immuni.2011.07.009
Ma, F., Xu, S., Liu, X., Zhang, Q., Xu, X., Liu, M., … Cao, X. (2011). The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-gamma. Nat Immunol, 12(9), 861–869. https://doi.org/10.1038/ni.2073
Fu, Y., Chen, J., & Huang, Z. (2019). Recent progress in microRNA-based delivery systems for the treatment of human disease. ExRNA, 1(1), 24. https://doi.org/10.1186/s41544-019-0024-y
Dasgupta, I., & Chatterjee, A. (2021). Recent Advances in miRNA Delivery Systems. Methods and protocols, 4(1), 10. https://doi.org/10.3390/mps4010010
Tarhriz, V., Eyvazi, S., Musavi, M., Abasi, M., Sharifi, K., Ghanbarian, H., & Hejazi, M. S. (2019). Transient induction of Cdk9 in the early stage of differentiation is critical for myogenesis. Journal of Cellular Biochemistry, 120(11), 18854–18861. https://doi.org/10.1002/jcb.29204
Ha, D., Yang, N., & Nadithe, V. (2016). Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharmaceutica Sinica B, 6(4), 287–296. https://doi.org/https://doi.org/10.1016/j.apsb.2016.02.001
Simons, M., & Raposo, G. (2009). Exosomes--vesicular carriers for intercellular communication. Current opinion in cell biology, 21 4, 575–581.
Ji, C., & Guo, X. (2019). The clinical potential of circulating microRNAs in obesity. Nature Reviews Endocrinology, 15(12), 731–743. https://doi.org/10.1038/s41574-019-0260-0
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011). Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nature Biotechnology, 29(4), 341–345. https://doi.org/10.1038/nbt.1807
Bolandi, Z., Hosseini Rad, S. M. A., Soudi, S., Hashemi, S. M., & Ghanbarian, H. (2018). A simple and highly efficient method for transduction of human adipose-derived mesenchymal stem cells. Journal of cellular biochemistry. https://doi.org/10.1002/jcb.27453
Bolandi, Z., Mokhberian, N., Eftekhary, M., Sharifi, K., Soudi, S., Hashemi, S. M., … Beheshti, S. (2020). Adipose derived mesenchymal stem cell exosomes loaded with miR-10a promote the differentiation of Th17 and Treg from naive CD4 + T cell. Life Sciences, 259.
Smith, K. M., Guerau-de-Arellano, M., Costinean, S., Williams, J. L., Bottoni, A., Mavrikis Cox, G., … Whitacre, C. C. (2012). miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis. J Immunol, 189(4), 1567–1576. https://doi.org/10.4049/jimmunol.1103171
Kwon, J. J., Factora, T. D., Dey, S., & Kota, J. (2018). A Systematic Review of miR-29 in Cancer. Molecular therapy oncolytics, 12, 173–194. https://doi.org/10.1016/j.omto.2018.12.011
Xu, H., Cheung, I. Y., Guo, H.-F., & Cheung, N.-K. V. (2009). MicroRNA miR-29 Modulates Expression of Immunoinhibitory Molecule B7-H3: Potential Implications for Immune Based Therapy of Human Solid Tumors. Cancer Research, 69(15), 6275 LP – 6281. https://doi.org/10.1158/0008-5472.CAN-08-4517
Szabo, S. J., Sullivan, B. M., Peng, S. L., & Glimcher, L. H. (2003). Molecular Mechanisms RegulatinG Th1 Immune Responses. Annual Review of Immunology, 21(1), 713–758. https://doi.org/10.1146/annurev.immunol.21.120601.140942
Chen, W., Huang, Y., Han, J., Yu, L., Li, Y., Lu, Z., … Xiao, Y. (2016). Immunomodulatory effects of mesenchymal stromal cells-derived exosome. Immunologic Research, 64(4), 831–840. https://doi.org/10.1007/s12026-016-8798-6
Hosseini, K., Ranjbar, M., Pirpour Tazehkand, A., Asgharian, P., Montazersaheb, S., Tarhriz, V., & Ghasemnejad, T. (2022). Evaluation of exosomal non-coding RNAs in cancer using high-throughput sequencing. Journal of Translational Medicine, 20(1), 30. https://doi.org/10.1186/s12967-022-03231-y
Luckheeram, R. V., Zhou, R., Verma, A. D., & Xia, B. (2012). CD4⁺T cells: differentiation and functions. Clinical & developmental immunology, 2012, 925135. https://doi.org/10.1155/2012/925135
Gorelik, L., Constant, S., & Flavell, R. A. (2002). Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. The Journal of experimental medicine, 195(11), 1499–1505. https://doi.org/10.1084/jem.20012076
Chauhan, S. K., Saban, D. R., Lee, H. K., & Dana, R. (2009). Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. Journal of immunology (Baltimore, Md. : 1950), 182(1), 148–153. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2610348/
Xuan, J., Guo, S., Huang, A., Xu, H., Shao, M., Yang, Y., & Wen, W. (2017). MiR-29a and miR-652 Attenuate Liver Fibrosis by Inhibiting the Differentiation of CD4+ T Cells. Cell Structure and Function, 42(2), 95–103. https://doi.org/10.1247/csf.17005
Brain, O., Owens, B. M. J., Pichulik, T., Allan, P., Khatamzas, E., Leslie, A., … Simmons, A. (2013). The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release. Immunity, 39(3), 521–536. https://doi.org/10.1016/j.immuni.2013.08.035

Download PDF

Journal Publication

published 19 Sep, 2023

Read the published version in Molecular Biology Reports →

Editorial decision: Minor Revisions Needed
24 Jul, 2023
Reviewers agreed at journal
30 Jun, 2023
Reviewers invited by journal
12 Jun, 2023
Editor assigned by journal
30 May, 2023
First submitted to journal
28 May, 2023

You are reading this latest preprint version

In vitro naive CD4⁺ T cells differentiation upon treatment with miR-29b-loaded exosomes from Mesenchymal Stem Cells

Status:

Journal Publication

Version 1

Abstract

Figures

Introduction

Materials and methods

AMSCs isolation and culture from adipose tissue

AMSCs characterization

Exosomes purification from AMSCs conditioned media

Scanning electron microscopy examination

Transmission electron microscopy examination

Exosomes size distribution analysis

Exosomes Immunophenotyping

miR-29b1-3p mimic loading into exosomes

Splenocytes isolation and nCD4 cell purification

Exosomes treatment

PKH67 labeling of exosomes

ELISA of cytokines

Real-time PCR assay

Analysis of regulatory T cells frequency

Statistical data analysis

Results

Identification of exosomes

Exosomes were internalized by nCD4 cells and miRNA-29b were delivered into the cells

Tbx21 and RORγt expression inhibition in nCD4 cells following miR-29b enriched exosomes treatment

Increased CD4CD25Foxp3 Cells frequency upon miR-29b loaded exosomes treatment

Discussion

Conclusion

Abbreviations

Declarations

References

Status:

Journal Publication

Version 1